Tchaikapharma High Quality Medicines AD is a leading Bulgarian pharmaceutical company specializing in the development, manufacturing, and distribution of generic and in-licensed medicines. Founded in 1999 and headquartered in Sofia, it focuses on providing affordable, high-quality therapeutic solutions for socially significant diseases, adhering to Good Manufacturing Practice (GMP) standards. The company's diverse portfolio includes products for anesthesia, anti-inflammatory and anti-rheumatic treatments, antibiotics, cardiovascular conditions, digestive issues, diabetes, nervous system disorders, over-the-counter remedies, respiratory ailments, oncology, and nutritional supplements. As the manufacturing arm of Commercial League Healthcare Group, it boasts advanced facilities with 2,181 square meters of production space, capable of producing 500 million tablets annually across 1,140 batches. Tchaikapharma went public in 2015, with shares traded on the Bulgarian Stock Exchange, achieving a market capitalization of BGN 1.36 billion and demonstrating consistent profit growth through new product launches and cost optimization. Employing around 218 staff under CEO Biser Georgiev, it plays a pivotal role in enhancing access to essential healthcare in Bulgaria and European markets.